Giacomo Calini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giacomo Calini has a total of 197 co-authors. Here are the top co-authors by number of shared publications:
- Matteo Rottoli
Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy
20 shared publications - Stefano Cardelli
Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
12 shared publications - Solafah Abdalla
Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, USA
8 shared publications - David W. Larson
Department of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN
7 shared publications Gilberto Poggioli
Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
7 shared publications- Tommaso Violante
Surgery of the Alimetary Tract, Alma Mater Studiorum Bologna University, Bologna, Italy
7 shared publications
Latest Publications
- 26 October 2026
- Published by Springer Nature in Updates in Surgery
- p. 1-14
Textbook outcomes after colon and rectal cancer surgery: results of a multicentre national study
- 26 October 2026
- Published by Springer Nature in Updates in Surgery
- p. 1-14
Textbook outcomes after colon and rectal cancer surgery: results of a multicentre national study
- 24 October 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 1131
Robotic vs. laparoscopic IPAA in a high-volume referral centre: a retrospective observational study
Ileal pouch-anal anastomosis (IPAA) represents the gold standard in ulcerative colitis patients refractory to medical therapy. While laparoscopy is a well-established alternative to open surgery, further comparative evidence between laparoscopy and robotic approaches is required. This study aims to evaluate intraoperative performance and short-term postoperative outcomes in laparoscopic and robotic IPAA in a high-volume referral centre. This retrospective single-centre study evaluated consecutive patients undergoing minimally invasive proctectomy with IPAA and diverting loop ileostomy between 2017 and 2025 at Sant’ Orsola University Hospital, Bologna. Demographic, clinical, surgical, and postoperative data were compared between the laparoscopic and robotic cohorts using a propensity score-matched analysis. This study included 169 patients: 131 in the laparoscopic group and 38 in the robotic one. Demographic characteristics were comparable. The robotic cohort presented a lower conversion rate, though this did not reach statistical significance (13.0% vs. 2.6%, p = 0.078). On the other hand, it presented a faster return to oral diet (p < 0.001). Length of stay, duration of surgery and overall postoperative complications were comparable. The laparoscopic cohort experienced more severe complications (7% Clavien-Dindo ≥ III), while the robotic cohort did not exceed a Grade II. No robotic cases required reoperation at 30 days, compared to 2.3% in the laparoscopic group. Robotic IPAA yielded results comparable to laparoscopy regarding length of stay, duration of surgery and rate of complications. However, the robotic approach showcased a trend towards decreased conversion and 30-day reoperation. It was also associated with decreased complication severity, and faster return to an oral diet, suggesting a potential to expedite and enhance postoperative recovery.
- 24 October 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 1131
Robotic vs. laparoscopic IPAA in a high-volume referral centre: a retrospective observational study
Ileal pouch-anal anastomosis (IPAA) represents the gold standard in ulcerative colitis patients refractory to medical therapy. While laparoscopy is a well-established alternative to open surgery, further comparative evidence between laparoscopy and robotic approaches is required. This study aims to evaluate intraoperative performance and short-term postoperative outcomes in laparoscopic and robotic IPAA in a high-volume referral centre. This retrospective single-centre study evaluated consecutive patients undergoing minimally invasive proctectomy with IPAA and diverting loop ileostomy between 2017 and 2025 at Sant’ Orsola University Hospital, Bologna. Demographic, clinical, surgical, and postoperative data were compared between the laparoscopic and robotic cohorts using a propensity score-matched analysis. This study included 169 patients: 131 in the laparoscopic group and 38 in the robotic one. Demographic characteristics were comparable. The robotic cohort presented a lower conversion rate, though this did not reach statistical significance (13.0% vs. 2.6%, p = 0.078). On the other hand, it presented a faster return to oral diet (p < 0.001). Length of stay, duration of surgery and overall postoperative complications were comparable. The laparoscopic cohort experienced more severe complications (7% Clavien-Dindo ≥ III), while the robotic cohort did not exceed a Grade II. No robotic cases required reoperation at 30 days, compared to 2.3% in the laparoscopic group. Robotic IPAA yielded results comparable to laparoscopy regarding length of stay, duration of surgery and rate of complications. However, the robotic approach showcased a trend towards decreased conversion and 30-day reoperation. It was also associated with decreased complication severity, and faster return to an oral diet, suggesting a potential to expedite and enhance postoperative recovery.
- Open Access
- 24 August 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (11) , 9910-9920
Outcomes of restorative proctectomy and ileal pouch-anal anastomosis: a matched-cohort analysis of robot-assisted, laparoscopic, and open surgery
Background: Ileal pouch-anal anastomosis (IPAA) remains the gold standard for restorative proctocolectomy, yet its technical complexity has limited widespread minimally invasive adoption. Robotic surgery was introduced to overcome the ergonomic and visualization challenges of laparoscopy, but comparative evidence among open, laparoscopic, and robot-assisted IPAA in tertiary care remains scarce. Methods: A matched-cohort analysis was performed on adult patients undergoing proctectomy with IPAA for ulcerative and indeterminate colitis (January 2005–September 2025) at a tertiary referral center. Patients were stratified by surgical approach: open, laparoscopic, and robot-assisted. The robot-assisted cohort included only cases performed with the modular Hugo™ RAS platform. Primary endpoints were total operative time and 30-day postoperative surgical complications. Multivariable regression, propensity score matching, and G-computation were applied to adjust for confounders such as age, BMI, ASA class, disease duration, and biologic exposure. Results: Among 764 patients, 573 underwent open, 145 laparoscopic, and 46 robot-assisted IPAA. Adjusted analyses demonstrated no significant differences in 30-day surgical complications between robot-assisted and laparoscopic (OR 1.56, 95% CI 0.63–3.90) or open (OR 1.40, 95% CI 0.57–3.44) approaches. Both minimally invasive techniques yielded faster bowel function recovery (− 1.2 days vs open, p < 0.001) and reduced hospital stay (− 4.1 days for robot-assisted, − 4.7 days for laparoscopic; p < 0.05). Operative time was longer in minimally invasive groups but similar between robot-assisted and laparoscopic cases. Conclusion: In expert centers, open, laparoscopic, and robot-assisted completion IPAA demonstrate preliminary safety, feasibility, and short-term equivalence. Minimally invasive approaches enhance postoperative recovery, and modern robotic platforms achieve procedural efficiency comparable to laparoscopy, although larger multicenter cohorts are needed to confirm equivalence for rare postoperative outcomes.
- 24 August 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (11) , 9910-9920
Open AccessOutcomes of restorative proctectomy and ileal pouch-anal anastomosis: a matched-cohort analysis of robot-assisted, laparoscopic, and open surgery
Background: Ileal pouch-anal anastomosis (IPAA) remains the gold standard for restorative proctocolectomy, yet its technical complexity has limited widespread minimally invasive adoption. Robotic surgery was introduced to overcome the ergonomic and visualization challenges of laparoscopy, but comparative evidence among open, laparoscopic, and robot-assisted IPAA in tertiary care remains scarce. Methods: A matched-cohort analysis was performed on adult patients undergoing proctectomy with IPAA for ulcerative and indeterminate colitis (January 2005–September 2025) at a tertiary referral center. Patients were stratified by surgical approach: open, laparoscopic, and robot-assisted. The robot-assisted cohort included only cases performed with the modular Hugo™ RAS platform. Primary endpoints were total operative time and 30-day postoperative surgical complications. Multivariable regression, propensity score matching, and G-computation were applied to adjust for confounders such as age, BMI, ASA class, disease duration, and biologic exposure. Results: Among 764 patients, 573 underwent open, 145 laparoscopic, and 46 robot-assisted IPAA. Adjusted analyses demonstrated no significant differences in 30-day surgical complications between robot-assisted and laparoscopic (OR 1.56, 95% CI 0.63–3.90) or open (OR 1.40, 95% CI 0.57–3.44) approaches. Both minimally invasive techniques yielded faster bowel function recovery (− 1.2 days vs open, p < 0.001) and reduced hospital stay (− 4.1 days for robot-assisted, − 4.7 days for laparoscopic; p < 0.05). Operative time was longer in minimally invasive groups but similar between robot-assisted and laparoscopic cases. Conclusion: In expert centers, open, laparoscopic, and robot-assisted completion IPAA demonstrate preliminary safety, feasibility, and short-term equivalence. Minimally invasive approaches enhance postoperative recovery, and modern robotic platforms achieve procedural efficiency comparable to laparoscopy, although larger multicenter cohorts are needed to confirm equivalence for rare postoperative outcomes.
- Open Access
- 26 July 2026
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
The hostile abdomen dilemma: the safety of primary anastomosis in the presence of an intraoperative abscess in Crohn disease
Background: Encountering an intra-abdominal abscess during elective surgery for Crohn disease (CD) presents a clinical dilemma. While guidelines often recommend temporary fecal diversion, stomas carry substantial morbidity. Existing literature is heavily confounded by selection bias, obscuring the true safety of bowel reconstruction. This study evaluated the safety of primary anastomosis in the presence of an intraoperative abscess. Methods: A retrospective review of patients undergoing ileocecal resection for CD was conducted. To isolate the impact of the abscess and eliminate selection bias, an a priori multivariable logistic regression model and a 1:2 propensity score matched (PSM) analysis were utilized on the subcohort of patients who underwent primary anastomosis. The primary endpoint was the rate of 30-day postoperative complications. Results: Among the 810 included patients (210 with an intraoperative abscess, 600 without), an abscess significantly increased operative complexity, resulting in higher rates of open conversion (29.3% vs 10.3%, P < .001) and fecal diversion (24.8% vs 6.2%, P < .001). However, multivariable analysis demonstrated that an abscess was not an independent predictor of overall 30-day complications (odds ratio [OR], 1.25; P = .190). Furthermore, in the PSM cohort of 474 patients, rates of anastomotic leak (10.1% vs 11.7%, P = .718), overall complications (41.1% vs 38.0%, P = .571), and severe complications (8.2% vs 10.8%, P = .480) were statistically identical between the abscess and non-abscess groups. Conclusion: While an intraoperative abscess increases operative difficulty, it does not independently compromise anastomotic integrity. Primary anastomosis in an infected field is safe, allowing surgeons to spare appropriately selected patients at experienced centers the profound morbidity of an unnecessary stoma.
- 26 July 2026
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
Open AccessThe hostile abdomen dilemma: the safety of primary anastomosis in the presence of an intraoperative abscess in Crohn disease
Background: Encountering an intra-abdominal abscess during elective surgery for Crohn disease (CD) presents a clinical dilemma. While guidelines often recommend temporary fecal diversion, stomas carry substantial morbidity. Existing literature is heavily confounded by selection bias, obscuring the true safety of bowel reconstruction. This study evaluated the safety of primary anastomosis in the presence of an intraoperative abscess. Methods: A retrospective review of patients undergoing ileocecal resection for CD was conducted. To isolate the impact of the abscess and eliminate selection bias, an a priori multivariable logistic regression model and a 1:2 propensity score matched (PSM) analysis were utilized on the subcohort of patients who underwent primary anastomosis. The primary endpoint was the rate of 30-day postoperative complications. Results: Among the 810 included patients (210 with an intraoperative abscess, 600 without), an abscess significantly increased operative complexity, resulting in higher rates of open conversion (29.3% vs 10.3%, P < .001) and fecal diversion (24.8% vs 6.2%, P < .001). However, multivariable analysis demonstrated that an abscess was not an independent predictor of overall 30-day complications (odds ratio [OR], 1.25; P = .190). Furthermore, in the PSM cohort of 474 patients, rates of anastomotic leak (10.1% vs 11.7%, P = .718), overall complications (41.1% vs 38.0%, P = .571), and severe complications (8.2% vs 10.8%, P = .480) were statistically identical between the abscess and non-abscess groups. Conclusion: While an intraoperative abscess increases operative difficulty, it does not independently compromise anastomotic integrity. Primary anastomosis in an infected field is safe, allowing surgeons to spare appropriately selected patients at experienced centers the profound morbidity of an unnecessary stoma.
- Open Access
- 22 April 2026
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 30 (1)
Rethinking risk in Crohn’s surgery: age at onset fails to predict surgical outcomes after ileocecal resection, insights from a tertiary referral center
Background: Early age at diagnosis in Crohn’s disease is linked to aggressive phenotypes, yet evidence regarding its impact on surgical risk remains inconsistent. This study aimed to elucidate the relationship between age at diagnosis, utilizing Vienna and Montreal classifications, and surgical prognosis in patients undergoing ileocecal resection. Methods: A retrospective analysis of a prospective database identified 810 patients undergoing ileocecal resection between 2014 and 2022. Patients were stratified by Vienna (< 40 versus > 40 years) and Montreal (A1, A2, A3) classifications. Primary end points included 30-day overall complications, serious complications, reoperation and readmission. Statistical analysis employed multivariable regression, propensity score matching, G-computation and Random Forest models to adjust for confounders. Results: Baseline characteristics differed significantly: younger patients exhibited more penetrating disease and biologic exposure, while older patients had higher ASA scores and comorbidities. After robust adjustment, the Vienna and Montreal age classification showed no significant association with postoperative complications, serious complications, reoperation or readmission. Random Forest analysis consistently identified ASA score and comorbidities, rather than age at onset, as the dominant predictors of surgical outcomes. Conclusions: Age at diagnosis does not independently predict short-term surgical outcomes after ileocecal resection. Postoperative morbidity is driven primarily by general health markers, such as ASA score, rather than disease onset timing. These findings highlight the need for validated disease-specific risk scores.
- 22 April 2026
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 30 (1)
Open AccessRethinking risk in Crohn’s surgery: age at onset fails to predict surgical outcomes after ileocecal resection, insights from a tertiary referral center
Background: Early age at diagnosis in Crohn’s disease is linked to aggressive phenotypes, yet evidence regarding its impact on surgical risk remains inconsistent. This study aimed to elucidate the relationship between age at diagnosis, utilizing Vienna and Montreal classifications, and surgical prognosis in patients undergoing ileocecal resection. Methods: A retrospective analysis of a prospective database identified 810 patients undergoing ileocecal resection between 2014 and 2022. Patients were stratified by Vienna (< 40 versus > 40 years) and Montreal (A1, A2, A3) classifications. Primary end points included 30-day overall complications, serious complications, reoperation and readmission. Statistical analysis employed multivariable regression, propensity score matching, G-computation and Random Forest models to adjust for confounders. Results: Baseline characteristics differed significantly: younger patients exhibited more penetrating disease and biologic exposure, while older patients had higher ASA scores and comorbidities. After robust adjustment, the Vienna and Montreal age classification showed no significant association with postoperative complications, serious complications, reoperation or readmission. Random Forest analysis consistently identified ASA score and comorbidities, rather than age at onset, as the dominant predictors of surgical outcomes. Conclusions: Age at diagnosis does not independently predict short-term surgical outcomes after ileocecal resection. Postoperative morbidity is driven primarily by general health markers, such as ASA score, rather than disease onset timing. These findings highlight the need for validated disease-specific risk scores.
- Open Access
- 18 April 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (4) , e72569
External Auditory Canal Metastasis of Colorectal Adenocarcinoma: A Comprehensive Case Report
Metastatic colorectal adenocarcinoma with a single‐site metastasis to the external auditory canal is an exceedingly rare phenomenon. A multidisciplinary approach involving collaboration among various medical specialties is essential for optimizing patient care and improving survival outcomes.
- 18 April 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (4) , e72569
Open AccessExternal Auditory Canal Metastasis of Colorectal Adenocarcinoma: A Comprehensive Case Report
Metastatic colorectal adenocarcinoma with a single‐site metastasis to the external auditory canal is an exceedingly rare phenomenon. A multidisciplinary approach involving collaboration among various medical specialties is essential for optimizing patient care and improving survival outcomes.
- Open Access
- 22 February 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 133 (5) , 572-579
Association Between Colorectal Cancer Screening and Survival in Patients Older Than 70 Years: Results of A National Multicenter Retrospective Study
Background: Colorectal cancer screening mainly targets a population between 50 and 70 years of age; however, it is inconsistently implemented in people over 70. The aim of this study was to analyze the association between colorectal cancer (CRC) screening, postoperative mortality, and perioperative and oncologic outcomes in a large population of patients over 70 years of age who underwent surgery for CRC. Methods: Data regarding people over 70 who underwent CRC surgery were retrieved from a nationally validated retrospective database, including four consecutive years (2018–2021) and 81 centers. The patients were divided into two groups according to their participation in the CRC screening program: Screening versus No Screening. The outcomes of the study were 30‐day mortality; urgent, palliative and minimally invasive surgery rates; Clavien‐Dindo ≥ III; advanced oncologic stage; R0 resection and length of hospital stay (LOS). Logistic regression analysis was carried out and adjusted for multiple confounders. Results: Of the 10,346 patients over 70,676 were in the screening group, and 9670 were in the no screening group. At logistic regression, CRC screening was significantly associated with a reduction in 30‐day mortality (OR 0.41, 95% CI 0.18–0.92, p = 0.032), urgent surgery (OR 0.06, 95% CI 0.02–0.14, p < 0.001), palliative surgery (OR 0.32, 95% CI 0.19–0.54, p < 0.001), Clavien‐Dindo ≥ III complications (OR 0.69, 95% CI 0.51–0.93, p = 0.016) and advanced oncologic stage (OR 0.53, 95% CI 0.45–0.62, p < 0.001), and a significant increase in R0 resections (OR 3.15, 95% CI 1.67–5.94, p < 0.001) and laparoscopic surgery (OR 1.93, 95% CI 1.57–2.38, p < 0.001). The crude and adjusted Odds Ratio similarity confirmed this correlation, regardless of the comorbidities and confounders. Conclusions: Adherence to CRC screening should be further encouraged and standardized for people over 70.
- 22 February 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 133 (5) , 572-579
Open AccessAssociation Between Colorectal Cancer Screening and Survival in Patients Older Than 70 Years: Results of A National Multicenter Retrospective Study
Background: Colorectal cancer screening mainly targets a population between 50 and 70 years of age; however, it is inconsistently implemented in people over 70. The aim of this study was to analyze the association between colorectal cancer (CRC) screening, postoperative mortality, and perioperative and oncologic outcomes in a large population of patients over 70 years of age who underwent surgery for CRC. Methods: Data regarding people over 70 who underwent CRC surgery were retrieved from a nationally validated retrospective database, including four consecutive years (2018–2021) and 81 centers. The patients were divided into two groups according to their participation in the CRC screening program: Screening versus No Screening. The outcomes of the study were 30‐day mortality; urgent, palliative and minimally invasive surgery rates; Clavien‐Dindo ≥ III; advanced oncologic stage; R0 resection and length of hospital stay (LOS). Logistic regression analysis was carried out and adjusted for multiple confounders. Results: Of the 10,346 patients over 70,676 were in the screening group, and 9670 were in the no screening group. At logistic regression, CRC screening was significantly associated with a reduction in 30‐day mortality (OR 0.41, 95% CI 0.18–0.92, p = 0.032), urgent surgery (OR 0.06, 95% CI 0.02–0.14, p < 0.001), palliative surgery (OR 0.32, 95% CI 0.19–0.54, p < 0.001), Clavien‐Dindo ≥ III complications (OR 0.69, 95% CI 0.51–0.93, p = 0.016) and advanced oncologic stage (OR 0.53, 95% CI 0.45–0.62, p < 0.001), and a significant increase in R0 resections (OR 3.15, 95% CI 1.67–5.94, p < 0.001) and laparoscopic surgery (OR 1.93, 95% CI 1.57–2.38, p < 0.001). The crude and adjusted Odds Ratio similarity confirmed this correlation, regardless of the comorbidities and confounders. Conclusions: Adherence to CRC screening should be further encouraged and standardized for people over 70.
- 10 October 2025
- Published by Elsevier in Surgical Oncology
- Vol. 63, 102299
Rectal cancer surgery timing after neoadjuvant therapy: balancing downstaging and perioperative outcomes
- 10 October 2025
- Published by Elsevier in Surgical Oncology
- Vol. 63, 102299
Rectal cancer surgery timing after neoadjuvant therapy: balancing downstaging and perioperative outcomes
- Open Access
- 1 August 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (8) , 1870
Long-Term Outcomes of First-Line Anti-TNF Therapy for Chronic Inflammatory Pouch Conditions: A Multi-Centre Multi-National Study
Background/Objectives: Anti-tumour necrosis factor (anti-TNF) medications were historically commonly prescribed as the first-line biologic treatment for chronic inflammatory pouch conditions. However, their use in these conditions is mainly based on retrospective studies of relatively small numbers of patients with short follow up periods. We aimed to describe the long-term outcomes of first-line anti-TNF therapy in a large, multi-centre, multi-national patient cohort with chronic inflammatory pouch conditions. Methods: This was an observational, retrospective, multi-centre, multi-national study. We included patients with chronic inflammatory pouch conditions initially treated with anti-TNF drugs infliximab (IFX) or adalimumab (ADA), who had a follow up of at least 1 year. The primary outcome was anti-TNF treatment persistence, defined as continuation of anti-TNF throughout the study period. The secondary outcome was pouch failure, defined by the need for a defunctioning ileostomy or pouch excision. Results: We recruited 98 patients with chronic inflammatory pouch conditions initially treated with anti-TNF medications—63 (64.3%) treated with IFX and 35 (35.7%) treated with ADA. Average follow up length was 94.2 months (±54.5). At the end of the study period only 22/98 (22.4%) patients were still on anti-TNF treatment. In those in whom the first-line anti-TNF was discontinued, the median time to discontinuation was 12.2 months (range 5.1–26.9 months). The most common cause for anti-TNF discontinuation was lack of efficacy despite adequate serum drug levels and absence of anti-drug antibody formation (30 patients, 30.6%). Loss of response due to anti-drug antibody formation was the cause for discontinuation in 18 patients (18.4%), while 12 patients (12.2%) stopped treatment because of adverse events or safety concerns. Out of the 76 patients discontinuing anti-TNF treatment, 34 (34.7% of the cohort) developed pouch failure, and 42 (42.8% of the cohort) are currently treated with a different medical therapy. Conclusions: First-line anti-TNF therapy for chronic pouch inflammatory conditions is associated with low long-term persistence rates. This is due to a combination of lack of efficacy and adverse events. A significant percentage of patients initially treated with anti-TNF therapy develop pouch failure.
- 1 August 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (8) , 1870
Open AccessLong-Term Outcomes of First-Line Anti-TNF Therapy for Chronic Inflammatory Pouch Conditions: A Multi-Centre Multi-National Study
Background/Objectives: Anti-tumour necrosis factor (anti-TNF) medications were historically commonly prescribed as the first-line biologic treatment for chronic inflammatory pouch conditions. However, their use in these conditions is mainly based on retrospective studies of relatively small numbers of patients with short follow up periods. We aimed to describe the long-term outcomes of first-line anti-TNF therapy in a large, multi-centre, multi-national patient cohort with chronic inflammatory pouch conditions. Methods: This was an observational, retrospective, multi-centre, multi-national study. We included patients with chronic inflammatory pouch conditions initially treated with anti-TNF drugs infliximab (IFX) or adalimumab (ADA), who had a follow up of at least 1 year. The primary outcome was anti-TNF treatment persistence, defined as continuation of anti-TNF throughout the study period. The secondary outcome was pouch failure, defined by the need for a defunctioning ileostomy or pouch excision. Results: We recruited 98 patients with chronic inflammatory pouch conditions initially treated with anti-TNF medications—63 (64.3%) treated with IFX and 35 (35.7%) treated with ADA. Average follow up length was 94.2 months (±54.5). At the end of the study period only 22/98 (22.4%) patients were still on anti-TNF treatment. In those in whom the first-line anti-TNF was discontinued, the median time to discontinuation was 12.2 months (range 5.1–26.9 months). The most common cause for anti-TNF discontinuation was lack of efficacy despite adequate serum drug levels and absence of anti-drug antibody formation (30 patients, 30.6%). Loss of response due to anti-drug antibody formation was the cause for discontinuation in 18 patients (18.4%), while 12 patients (12.2%) stopped treatment because of adverse events or safety concerns. Out of the 76 patients discontinuing anti-TNF treatment, 34 (34.7% of the cohort) developed pouch failure, and 42 (42.8% of the cohort) are currently treated with a different medical therapy. Conclusions: First-line anti-TNF therapy for chronic pouch inflammatory conditions is associated with low long-term persistence rates. This is due to a combination of lack of efficacy and adverse events. A significant percentage of patients initially treated with anti-TNF therapy develop pouch failure.